Research from two independent clinical trials demonstrated the ability of new drugs in treating the most challenging prostate cancers that reject standard hormonal therapy, the New York Times reports.

The U.S. Food and Drug Administration (FDA) announced it has approved domestic production of technetium-99m (Tc-99m), the most commonly used radioactive imaging isotopes.

Pennsylvania researchers discovered opposed-phase MRI imaging is less accurate in detecting treated spinal metastases compared to those lesions that are untreated.

Breast cancer is the most common form of cancer among women. And a new study finds injecting oxygen-filled microbubbles into breast cancer makes tumors three times more responsive to radiation treatment, according to an International Journal of Radiation Oncology study.

High rates of incidental findings, limited risk-reward outcomes and unnecessary emotional stress suggest to one group of authors that lung cancer screening efforts need to be refined and the risk and benefits clearly communicated to better screen high-risk patients.

Researchers from Georgia have successfully stifled the production of a chemical sent by aggressive cancers to bone marrow allowing them to thrive in the body.

Ultrasound may not be as cutting-edge as, say, nuclear imaging or pack the punch of CT, but the technology that’s now more than a century old is making a comeback in unexpected avenues.

Researchers may be closer to detecting cancers before symptoms become apparent in patients, according to a recent article by NPR. Although more research needs to be conducted, the newly developed non-invasive blood test would detect eight common types of cancer, with the potential to open up possibilities in the field of oncology.